Ectopic Runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: Implications for breast cancer progression

Cancer Research

Volumn 69, Issue 17, 2009, Pages 6807-6814

  Pratap, Jitesh ^a   Imbalzano, Karen M ^a   Underwood, Jean M ^a   Cohet, Nathalie ^a   Gokul, Karthiga ^a   Akech, Jacqueline ^a   Van Wijnen, Andre J ^a   Stein, Janet L ^a   Imbalzano, Anthony N ^a   Nickerson, Jeffrey A ^a   Lian, Jane B ^a   Stein, Gary S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA4 INTEGRIN; INTERLEUKIN 8; KI 67 ANTIGEN; PROTEIN BCL 2; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RUNX2;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ECTOPIC BREAST; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY;

BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL POLARITY; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMAGING, THREE-DIMENSIONAL; MAMMARY GLANDS, HUMAN; MUTATION; NEOPLASM METASTASIS;

EID: 70149098945     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1471     Document Type: Article

References (43)

1. Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005;5:675-688 (Pubitemid 41486361)
2. Bissell MJ. Glandular structure and gene expression. Lessons from the mammary gland. Ann N Y Acad Sci 1998;842:1-6.
3. Harris RA, Eichholtz TJ, Hiles ID, Page MJ, O'Hare MJ. New model of ErbB-2 over-expression in human mammary luminal epithelial cells. Int J Cancer 1999;80:477-484 (Pubitemid 29019639)
4. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 2001;3:785-792 (Pubitemid 32842683)
5. Reginato MJ, Mills KR, Becker EB, et al. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol Cell Biol 2005;25:4591-4601
6. Blyth K, Cameron ER, Neil JC. The runx genes: gain or loss of function in cancer. Nat Rev Cancer 2005;5:376-387 (Pubitemid 40637829)
7. Zaidi SK, Pande S, Pratap J, et al. Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc Natl Acad Sci U S A 2007;104:19861-19866
8. Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999;23:166-175
9. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-124 (Pubitemid 34327521)
10. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-764 (Pubitemid 27516178)
11. Choi J-Y, Pratap J, Javed A, et al. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci U S A 2001;98:8650-8655 (Pubitemid 32678082)
12. Thomas DM, Johnson SA, Sims NA, et al. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol 2004;167:925-934
13. Nathan SS, Pereira BP, Zhou YF, et al. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma. Mol Biol Rep 2009;36:153-158
14. Selvamurugan N, Partridge NC. Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol Cell Biol Res Commun 2000;3:218-223 (Pubitemid 30602027)
15. Barnes GL, Hebert KE, Kamal M, et al. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases associated osteolytic disease. Cancer Res 2004;64:4506-4513 (Pubitemid 38856922)
16. Inman CK, Shore P. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J Biol Chem 2003;278:48684-48689 (Pubitemid 41079508)
17. Javed A, Barnes GL, Pratap J, et al. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo . Proc Natl Acad Sci U S A 2005;102:1454-1459 (Pubitemid 40209191)
18. Pratap J, Javed A, Languino LR, et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 2005;25:8581-8591 (Pubitemid 41369178)
19. Brubaker KD, Vessella RL, Brown LG, Corey E. Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. Prostate 2003;56:13-22. (Pubitemid 36613151)
20. Pratap J, Lian JB, Javed A, et al. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev 2006;25:589-600. (Pubitemid 46071865)
21. Pratap J, Wixted JJ, Gaur T, et al. Runx2 transcriptional activation of Indian hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res 2008;68:7795-7802
22. Underwood JM, Imbalzano KM, Weaver VM, Fischer AH, Imbalzano AN, Nickerson JA. The ultrastructure of MCF-10A acini. J Cell Physiol 2006;208:141-148
23. Afzal F, Pratap J, Ito K, et al. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol 2005;204:63-72. (Pubitemid 40776807)
24. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003;30:256-268 (Pubitemid 36677560)
25. Zaidi SK, Javed A, Pratap J, et al. Alterations in intranuclear localization of Runx2 affect biological activity. J Cell Physiol 2006;209:935-942 (Pubitemid 44665715)
26. Javed A, Afzal F, Bae JS, et al. Specific residues of RUNX2 are obligatory for formation of BMP2-Induced RUNX2-SMAD complex to promote osteoblast differentiation. Cells Tissues Organs 2009;189:133-137
27. Ishizawar R, Parsons SJ. c-Src and cooperating partners in human cancer. Cancer Cell 2004;6:209-214 (Pubitemid 39222033)
28. Weaver VM, Petersen OW, Wang F, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231-245 (Pubitemid 27167310)
29. Yano T, Ito K, Fukamachi H, et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor β-induced apoptosis. Mol Cell Biol 2006;26:4474-4488 (Pubitemid 43877568)
30. Eliseev RA, Dong YF, Sampson E, et al. Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis. Oncogene 2008;27:3605-3614 (Pubitemid 351793799)
31. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002;111:29-40.
32. Blyth K, Vaillant F, Hanlon L, et al. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. Cancer Res 2006;66:2195-2201 (Pubitemid 43294930)
33. Galindo M, Pratap J, Young DW, et al. The bone-specific expression of RUNX2 oscillates during the cell cycle to support a G1 related anti-proliferative function in osteoblasts. J Biol Chem 2005;280:20274-20285 (Pubitemid 40776725)
34. Qiao M, Shapiro P, Kumar R, Passaniti A. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. J Biol Chem 2004;279:42709-42718 (Pubitemid 39372157)
35. Yanochko GM, Eckhart W. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells. Breast Cancer Res 2006;8:R18. (Pubitemid 44377913)
36. Wang F, Hansen RK, Radisky D, et al. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 2002;94:1494-1503 (Pubitemid 35243746)
37. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 2002;277:36181-36187
38. Fujita T, Azuma Y, Fukuyama R, et al. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 2004;166:85-95. (Pubitemid 38931919)
39. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007;8:341-352
40. Kim ES, Kim MS, Moon A. TGF-β-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 2004;25:1375-1382
41. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-549 (Pubitemid 36808649)
42. Klampfer L, Zhang J, Zelenetz AO, Uchida H, Nimer SD. The AML1/ETO fusion protein activates transcription of BCL-2. Proc Natl Acad Sci U S A 1996;93:14059-14064 (Pubitemid 26424245)
43. Nor JE, Christensen J, Liu J, et al. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001;61:2183-2188 (Pubitemid 32692045)